Literature DB >> 19302244

Imbalance between T helper type 17 and T regulatory cells in patients with primary biliary cirrhosis: the serum cytokine profile and peripheral cell population.

G Rong1, Y Zhou, Y Xiong, L Zhou, H Geng, T Jiang, Y Zhu, H Lu, S Zhang, P Wang, B Zhang, R Zhong.   

Abstract

Primary biliary cirrhosis (PBC) is an organ-specific autoimmune liver disease characterized by progressive loss of intrahepatic small bile ducts. Cellular immune mechanisms involving T cell reaction are thought to be involved significantly in the pathogenesis of PBC. Recent studies have independently revealed enhanced T helper type 17 (Th17) response and weakened T regulatory cell (T(reg)) response in some autoimmune diseases, indicating a role of Th17/T(reg) imbalance in the pathogenesis of autoimmunity. This prompted us to investigate whether the Th17/T(reg) balance was broken in the peripheral blood of patients with PBC and, if it was, what cytokine circumstances might contribute to this imbalance. The expression of 11 Th17/T(reg) differentiation-related genes and serum concentrations of the corresponding cytokines in 36 patients with PBC, 28 patients with chronic hepatitis B and 28 healthy controls were measured by real-time quantitative-polymerase chain reaction and enzyme-linked immunosorbent assay respectively. Peripheral Th17 and T(reg) cells were analysed by flow cytometry. Th17-related cytokines were increased significantly in patients with PBC. Consistent with the cytokine profile, the Th17 cell population and retinoid-related orphan receptor gammat expression were increased markedly. In contrast, the T(reg) cell population and forkhead box P3 expression were decreased dramatically in the peripheral blood of patients with PBC. Our study revealed that the Th17/T(reg) imbalance, both cytokine profile and cell numbers, exists in patients with PBC, suggesting its potential role in the breakdown of immune self-tolerance in PBC. Interleukin-23, which characterized the imbalanced cytokine profile, may play an essential role in Th17-related human autoimmunity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19302244      PMCID: PMC2759468          DOI: 10.1111/j.1365-2249.2009.03898.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  45 in total

1.  A novel transcription factor, T-bet, directs Th1 lineage commitment.

Authors:  S J Szabo; S T Kim; G L Costa; X Zhang; C G Fathman; L H Glimcher
Journal:  Cell       Date:  2000-03-17       Impact factor: 41.582

Review 2.  Regulatory T cells in the control of immune pathology.

Authors:  K J Maloy; F Powrie
Journal:  Nat Immunol       Date:  2001-09       Impact factor: 25.606

3.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

4.  T(H)1 and T(H)2 cells: a historical perspective.

Authors:  Foo Y Liew
Journal:  Nat Rev Immunol       Date:  2002-01       Impact factor: 53.106

Review 5.  The lineage decisions of helper T cells.

Authors:  Kenneth M Murphy; Steven L Reiner
Journal:  Nat Rev Immunol       Date:  2002-12       Impact factor: 53.106

6.  Control of regulatory T cell development by the transcription factor Foxp3.

Authors:  Shohei Hori; Takashi Nomura; Shimon Sakaguchi
Journal:  Science       Date:  2003-01-09       Impact factor: 47.728

7.  Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17.

Authors:  Sudeepta Aggarwal; Nico Ghilardi; Ming-Hong Xie; Frederic J de Sauvage; Austin L Gurney
Journal:  J Biol Chem       Date:  2002-11-03       Impact factor: 5.157

8.  Gene expression of interleukin 18 in unstimulated peripheral blood mononuclear cells of patients with alcoholic cirrhosis.

Authors:  C Hanck; T Manigold; U Böcker; M Kurimoto; C B Kölbel; M V Singer; S Rossol
Journal:  Gut       Date:  2001-07       Impact factor: 23.059

9.  Management of primary biliary cirrhosis. The American Association for the Study of Liver Diseases practice guidelines.

Authors:  E J Heathcote
Journal:  Hepatology       Date:  2000-04       Impact factor: 17.425

10.  Does a betaretrovirus infection trigger primary biliary cirrhosis?

Authors:  Lizhe Xu; Zhiwei Shen; Linsheng Guo; Brent Fodera; Adrian Keogh; Ruth Joplin; Barbara O'Donnell; James Aitken; William Carman; James Neuberger; Andrew Mason
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-27       Impact factor: 12.779

View more
  70 in total

Review 1.  Primary biliary cirrhosis: From bench to bedside.

Authors:  Elias Kouroumalis; George Notas
Journal:  World J Gastrointest Pharmacol Ther       Date:  2015-08-06

2.  The immunobiology of colitis and cholangitis in interleukin-23p19 and interleukin-17A deleted dominant negative form of transforming growth factor beta receptor type II mice.

Authors:  Yugo Ando; Guo-Xiang Yang; Masanobu Tsuda; Kazuhito Kawata; Weici Zhang; Takahiko Nakajima; Koichi Tsuneyama; Patrick Leung; Zhe-Xiong Lian; Kazuichi Okazaki; William M Ridgway; Gary L Norman; Aftab A Ansari; Xiao-Song He; Ross L Coppel; M Eric Gershwin
Journal:  Hepatology       Date:  2012-10       Impact factor: 17.425

3.  Elevated Th17 cells accompanied by decreased regulatory T cells and cytokine environment in infants with biliary atresia.

Authors:  Ying Yang; Yong-jun Liu; Shao-tao Tang; Li Yang; Jun Yang; Guo-qing Cao; Jing-hui Zhang; Xin-xin Wang; Yong-zhong Mao
Journal:  Pediatr Surg Int       Date:  2013-12       Impact factor: 1.827

4.  Etiopathogenesis of primary biliary cirrhosis: an overview of recent developments.

Authors:  Palak J Trivedi; Sue Cullen
Journal:  Hepatol Int       Date:  2012-03-20       Impact factor: 6.047

5.  Gene-disease associations identify a connectome with shared molecular pathways in human cholangiopathies.

Authors:  Zhenhua Luo; Anil G Jegga; Jorge A Bezerra
Journal:  Hepatology       Date:  2018-01-02       Impact factor: 17.425

Review 6.  Role of autoimmunity in primary biliary cirrhosis.

Authors:  Tian-Yan Shi; Feng-Chun Zhang
Journal:  World J Gastroenterol       Date:  2012-12-28       Impact factor: 5.742

7.  Epigenetics in the Primary Biliary Cholangitis and Primary Sclerosing Cholangitis.

Authors:  Angela C Cheung; Nicholas F LaRusso; Gregory J Gores; Konstantinos N Lazaridis
Journal:  Semin Liver Dis       Date:  2017-05-31       Impact factor: 6.115

8.  Analysis of regulatory T cells and IgG4-positive plasma cells among patients of IgG4-related sclerosing cholangitis and autoimmune liver diseases.

Authors:  Masanori Koyabu; Kazushige Uchida; Hideaki Miyoshi; Yutaku Sakaguchi; Toshiro Fukui; Hiroki Ikeda; Makoto Takaoka; Junko Hirohara; Akiyoshi Nishio; Yoshiko Uemura; Shinji Uemoto; Kazuichi Okazaki
Journal:  J Gastroenterol       Date:  2010-01-20       Impact factor: 7.527

9.  Hepatitis C virus promotes T-helper (Th)17 responses through thymic stromal lymphopoietin production by infected hepatocytes.

Authors:  Hai-Chon Lee; Sung-Sang J Sung; Peter D Krueger; Yoon-Ah Jo; Hugo R Rosen; Steven F Ziegler; Young S Hahn
Journal:  Hepatology       Date:  2013-03-14       Impact factor: 17.425

10.  Foxp3+ regulatory T cells, Th17 effector cells, and cytokine environment in inflammatory bowel disease.

Authors:  Nicola Eastaff-Leung; Nicholas Mabarrack; Angela Barbour; Adrian Cummins; Simon Barry
Journal:  J Clin Immunol       Date:  2010-01       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.